Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 401–500 of 1,018
Montreal Cognitive Assessment (MoCA): Validation study for Frontotemporal Dementia
Freitas, S., Simões, M. R., Alves, L., Duro, D., & Santana, I. J. (2012) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988712455235 · Cited by 123
Biomarker-based dissection of neurodegenerative diseases
Olsson, B., Zetterberg, H., Hampel, H. J., & Blennow, K. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.04.006 · Cited by 108
Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms
Huin, V., Barbier, M., Bottani, A., Lobrinus, J. A., Clot, F., Lamari, F., Chat, L., Rucheton, B., Fluchère, F., Auvin, S., et al. (2020) · Brain · doi:10.1093/brain/awz377 · Cited by 96
“nt mode of transmission. Most of them carry heterozygous pathogenic variants in C9orf72, GRN and MAPT genes. Among them, GRN (granulin precursor, OMIM *138945) is responsible for 20% of familial FTD (Baker et al., 2006; Cruts et al., 2006). GRN mutations lead to bvFTD or PPA phenotypes and, less frequently, to a corti…”
BackgroundInfluentialIrwin, D. J., Trojanowski, J. Q., & Grossman, M. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00006 · Cited by 96
“…(Figure 1B), despite heterogeneous expression of FTLD clinical syndromes, and include pathogenic mutations in the gene for progranulin (GRN) (Baker et al., 2006; Cruts et al., 2006), tau (MAPT) (Hutton et al., 1998), and C9orf72 (C9orf72) (Dejesus-Hernandez et al., 2011; Renton et al.,…”
BackgroundParkinsonian syndrome in familial frontotemporal dementia
Siuda, J., Fujioka, S., & Wszolek, Z. K. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.06.004 · Cited by 96
Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS
Bennion Callister, J., & Pickering-Brown, S. M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.001 · Cited by 95
Self-citationTalking Point on the role of presenilin mutations in Alzheimer disease
Strooper, B. D. (2007) · Cited by 97
Kanazawa, M., Takahashi, T., Nishizawa, M., & Shimohata, T. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv16006 · Cited by 102
Emerging new roles of the lysosome and neuronal ceroid lipofuscinoses
Mukherjee, A. B., Appu, A. P., Sadhukhan, T., Casey, S., Mondal, A., Zhang, Z., & Bagh, M. B. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0300-6 · Cited by 96
Nuclear pore complexes — a doorway to neural injury in neurodegeneration
Coyne, A. N., & Rothstein, J. D. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00653-6 · Cited by 96
Foulds, P. G., Davidson, Y., Mishra, M., Hobson, D. J., Humphreys, K. M., Taylor, M., Johnson, N., Weintraub, S., Akiyama, H., Arai, T., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0594-0 · Cited by 95
Self-citationGhidoni, R., Stoppani, E., Rossi, G., Piccoli, E., Albertini, V., Paterlini, A., Glionna, M., Pegoiani, E., Agnati, L. F., Fenoglio, C., et al. (2012) · Neurodegenerative Diseases · doi:10.1159/000333132 · Cited by 96
Seelaar, H., Jurgen Schelhaas, H., Azmani, A., Kusters, B., Rosso, S., Majoor-Krakauer, D., de Rijik, M. C., Rizzu, P., ten Brummelhuis, M., van Doorn, P. A., et al. (2007) · Brain · doi:10.1093/brain/awm024 · Cited by 96
Sun, Y., & Chakrabartty, A. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01088 · Cited by 112
Mishra, M., Paunesku, T., Woloschak, G. E., Siddique, T., Zhu, L., Lin, S., Greco, K., & Bigio, E. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0240-7 · Cited by 95
Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum
Ji, A.-L., Zhang, X., Chen, W.-W., & Huang, W.-J. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104271 · Cited by 96
Götzl, J. K., Colombo, A.-V., Fellerer, K., Reifschneider, A., Werner, G., Tahirovic, S., Haass, C., & Capell, A. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0281-5 · Cited by 94
TAR DNA-Binding Protein 43 Accumulation in Protein Aggregate Myopathies
Olivé, M., Janué, A., Moreno, D., Gámez, J., Torrejón-Escribano, B., & Ferrer, I. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181996d8f · Cited by 95
Loss of TMEM106B and PGRN leads to severe lysosomal abnormalities and neurodegeneration in mice
Feng, T., Mai, S., Roscoe, J. M., Sheng, R. R., Ullah, M., Zhang, J., Katz, I. I., Yu, H., Xiong, W., & Hu, F. (2020) · The EMBO Reports · doi:10.15252/embr.202050219 · Cited by 94
“…PGRN haploinsufficiency is a leading cause of FTLD with ubiquitin-positive TDP-43 aggregates in humans (Baker et al , 2006; Cruts et al , 2006; Gass et al , 2006; Neumann et al , 2006), PGRN deficiency in mice does not result in robust accumulation of ubiquitinated proteins or TDP-43…”
Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia
Simon, M. J., Logan, T., DeVos, S. L., & Di Paolo, G. (2023) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.09.006 · Cited by 94
Progranulin locus deletion in frontotemporal dementia
Gijselinck, I., van der Zee, J., Engelborghs, S., Goossens, D., Peeters, K., Mattheijssens, M., Corsmit, E., Del-Favero, J., De Deyn, P. P., Van Broeckhoven, C., et al. (2008) · Human Mutation · doi:10.1002/humu.20651 · Cited by 94
Steinacker, P., Huss, A., Mayer, B., Grehl, T., Grosskreutz, J., Borck, G., Kuhle, J., Lulé, D., Meyer, T., Oeckl, P., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2016.1241279 · Cited by 92
Moisse, K., Mepham, J., Volkening, K., Welch, I., Hill, T., & Strong, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.023 · Cited by 93
Su, X., Broach, J. R., Connor, J. R., Gerhard, G. S., & Simmons, Z. (2014) · Muscle & Nerve · doi:10.1002/mus.24198 · Cited by 102
Moncini, S., Lunghi, M., Valmadre, A., Grasso, M., Vescovo, V. D., Riva, P., Denti, M. A., & Venturin, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0002-4 · Cited by 96
Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS
Ogaki, K., Li, Y., Takanashi, M., Ishikawa, K., Kobayashi, T., Nonaka, T., Hasegawa, M., Kishi, M., Yoshino, H., Funayama, M., et al. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.06.019 · Cited by 102
Borroni, B., Alberici, A., Premi, E., Archetti, S., Garibotto, V., Agosti, C., Gasparotti, R., Di Luca, M., Perani, D., & Padovani, A. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0623 · Cited by 94
Association Between Progranulin and Gaucher Disease
Jian, J., Zhao, S., Tian, Q.-Y., Liu, H., Zhao, Y., Chen, W.-C., Grunig, G., Torres, P. A., Wang, B. C., Zeng, B., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.004 · Cited by 93
Menzel, L., Kleber, L., Friedrich, C., Hummel, R., Dangel, L., Winter, J., Schmitz, K., Tegeder, I., & Schäfer, M. K. E. (2017) · Glia · doi:10.1002/glia.23091 · Cited by 93
Lashley, T., Rohrer, J. D., Bandopadhyay, R., Fry, C., Ahmed, Z., Isaacs, A. M., Brelstaff, J. H., Borroni, B., Warren, J. D., Troakes, C., et al. (2011) · Brain · doi:10.1093/brain/awr160 · Cited by 92
Cause or Effect: Misregulation of microRNA Pathways in Neurodegeneration
Gascon, E., & Gao, F.-B. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00048 · Cited by 69
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD
Pang, W., & Hu, F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15255 · Cited by 103
Bossù, P., Salani, F., Alberici, A., Archetti, S., Bellelli, G., Galimberti, D., Scarpini, E., Spalletta, G., Caltagirone, C., Padovani, A., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-65 · Cited by 91
Prosaposin is a regulator of progranulin levels and oligomerization
Nicholson, A. M., Finch, N. A., Almeida, M., Perkerson, R. B., van Blitterswijk, M., Wojtas, A., Cenik, B., Rotondo, S., Inskeep, V., Almasy, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms11992 · Cited by 91
Self-citationYokota, O., Tsuchiya, K., Arai, T., Yagishita, S., Matsubara, O., Mochizuki, A., Tamaoka, A., Kawamura, M., Yoshida, H., Terada, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0493-4 · Cited by 95
Reifschneider, A., Robinson, S., van Lengerich, B., Gnörich, J., Logan, T., Heindl, S., Vogt, M. A., Weidinger, E., Riedl, L., Wind, K., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109108 · Cited by 89
PGRN protects against colitis progression in mice in an IL-10 and TNFR2 dependent manner
Wei, F., Zhang, Y., Jian, J., Mundra, J. J., Tian, Q., Lin, J., Lafaille, J. J., Tang, W., Zhao, W., Yu, X., et al. (2014) · Scientific Reports · doi:10.1038/srep07023 · Cited by 90
Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia
Arrant, A. E., Filiano, A. J., Unger, D. E., Young, A. H., & Roberson, E. D. (2017) · Brain · doi:10.1093/brain/awx060 · Cited by 87
Genotype–phenotype links in frontotemporal lobar degeneration
Mossevelde, S. V., Engelborghs, S., van der Zee, J., & Broeckhoven, C. V. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0009-8 · Cited by 107
Jiao, J., Herl, L. D., Farese, R. V., & Gao, F.-B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010551 · Cited by 89
Womack, K. B., Diaz-Arrastia, R., Aizenstein, H. J., Arnold, S. E., Barbas, N. R., Boeve, B. F., Clark, C. M., DeCarli, C. S., Jagust, W. J., Leverenz, J. B., et al. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.295 · Cited by 85
Self-citationProgranulin as a biomarker and potential therapeutic agent
Abella, V., Pino, J., Scotece, M., Conde, J., Lago, F., González-Gay, M. Á., Mera, A., Gómez, R., Mobasheri, A., & Gualillo, O. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.006 · Cited by 94
Denk, J., Oberhauser, F., Kornhuber, J., Wiltfang, J., Fassbender, K., Schroeter, M. L., Volk, A. E., Diehl-Schmid, J., Prudlo, J., Danek, A., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0197329 · Cited by 89
Gerrits, E., Giannini, L. A. A., Brouwer, N., Melhem, S., Seilhean, D., Le Ber, I., The Brainbank Neuro-CEB Neuropathology Network, Kamermans, A., Kooij, G., de Vries, H. E., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01124-3 · Cited by 88
Boxer, A. L., & Boeve, B. F. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c345e · Cited by 88
Self-citationAbnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress
Woulfe, J. M. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00819.x · Cited by 88
Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease
Levy, J. A., & Chelune, G. J. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988707308806 · Cited by 115
Talbot, K., & Ansorge, O. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl202 · Cited by 88
Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers
Meeter, L. H. H., Patzke, H., Loewen, G., Dopper, E. G. P., Pijnenburg, Y. A. L., van Minkelen, R., & van Swieten, J. C. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000447738 · Cited by 87
Tapia, L., Milnerwood, A., Guo, A., Mills, F., Yoshida, E., Vasuta, C., Mackenzie, I. R., Raymond, L., Cynader, M., Jia, W., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6244-10.2011 · Cited by 86
Self-citationFrontotemporal Dementia and Mania
Woolley, J. D., Wilson, M. R., Hung, E. K., Gorno-Tempini, M.-L., Miller, B. L., & Shim, J. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07061001 · Cited by 89
Rab8, POSH, and TAK1 regulate synaptic growth in a Drosophila model of frontotemporal dementia
West, R. J. H., Lu, Y., Marie, B., Gao, F.-B., & Sweeney, S. T. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201404066 · Cited by 87
Corticobasal Syndrome Associated With the A9D Progranulin Mutation
Spina, S., Murrell, J. R., Huey, E. D., Wassermann, E. M., Pietrini, P., Grafman, J., & Ghetti, B. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181567873 · Cited by 87
Pereson, S., Wils, H., Kleinberger, G., McGowan, E., Vandewoestyne, M., Van Broeck, B., Joris, G., Cuijt, I., Deforce, D., Hutton, M., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2580 · Cited by 87
Self-citationChertkow, H. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070795 · Cited by 86
Gene expression study on peripheral blood identifies progranulin mutations
Coppola, G., Karydas, A., Rademakers, R., Wang, Q., Baker, M., Hutton, M., Miller, B. L., & Geschwind, D. H. (2008) · Annals of Neurology · doi:10.1002/ana.21397 · Cited by 87
Self-citationrs5848 polymorphism and serum progranulin level
Hsiung, G.-Y. R., Fok, A., Feldman, H. H., Rademakers, R., & Mackenzie, I. R. A. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.10.009 · Cited by 87
Self-citationCharacteristics of frontotemporal dementia patients with a Progranulin mutation
Huey, E. D., Grafman, J., Wassermann, E. M., Pietrini, P., Tierney, M. C., Ghetti, B., Spina, S., Baker, M., Hutton, M., Elder, J. W., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20969 · Cited by 87
Self-citationZhan, L., Fan, L., Kodama, L., Sohn, P. D., Wong, M. Y., Mousa, G. A., Zhou, Y., Li, Y., & Gan, L. (2020) · eLife · doi:10.7554/elife.51796 · Cited by 86
Jensen, T. L., Gøtzsche, C. R., & Woldbye, D. P. D. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.695937 · Cited by 104
A review of genome mutation and Alzheimer's disease
Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 110
The Role of TDP-43 in Alzheimer’s Disease
Chang, X., Tan, M., Tan, L., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9264-5 · Cited by 90
Kocerha, J., Kauppinen, S., & Wahlestedt, C. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8066-1 · Cited by 91
Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice
Kawase, R., Ohama, T., Matsuyama, A., Matsuwaki, T., Okada, T., Yamashita, T., Yuasa-Kawase, M., Nakaoka, H., Nakatani, K., Inagaki, M., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt178 · Cited by 85
Mohagheghi, F., Prudencio, M., Stuani, C., Cook, C., Jansen-West, K., Dickson, D. W., Petrucelli, L., & Buratti, E. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv491 · Cited by 84
Self-citationCYLD is a causative gene for frontotemporal dementia – amyotrophic lateral sclerosis
Dobson-Stone, C., Hallupp, M., Shahheydari, H., Ragagnin, A. M. G., Chatterton, Z., Carew-Jones, F., Shepherd, C. E., Stefen, H., Paric, E., Fath, T., et al. (2020) · Brain · doi:10.1093/brain/awaa039 · Cited by 83
Molecular characterization of novel progranulin ( GRN ) mutations in frontotemporal dementia
Mukherjee, O., Wang, J., Gitcho, M. A., Chakraverty, S., Taylor‐Reinwald, L., Shears, S., Kauwe, J. S. K., Norton, J. B., Levitch, D., Bigio, E. H., et al. (2008) · Human Mutation · doi:10.1002/humu.20681 · Cited by 85
Carecchio, M., Fenoglio, C., Riz, M. A. D., Guidi, I., Comi, C., Cortini, F., Venturelli, E., Restelli, I., Cantoni, C., Bresolin, N., et al. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.07.011 · Cited by 83
Ahmad, S. T., Sweeney, S. T., Lee, J., Sweeney, N. T., & Gao, F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903134106 · Cited by 95
Initiative, F. T. A. D. N., Takahashi, H., Klein, Z. A., Bhagat, S. M., Kaufman, A. C., Kostylev, M. A., Ikezu, T., & Strittmatter, S. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1668-z · Cited by 83
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 83
Baird, D. A., Liu, J. Z., Zheng, J., Sieberts, S. K., Perumal, T., Elsworth, B., Richardson, T. G., Chen, C.-Y., Carrasquillo, M. M., Allen, M., et al. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009224 · Cited by 83
Pathogenic cysteine mutations affect progranulin function and production of mature granulins
Wang, J., Van Damme, P., Cruchaga, C., Gitcho, M. A., Vidal, J. M., Seijo‐Martínez, M., Wang, L., Wu, J. Y., Robberecht, W., & Goate, A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06546.x · Cited by 82
Current state and future directions of neurochemical biomarkers for Alzheimer's disease
de Jong, D., Kremer, B. P. H., Olde Rikkert, M. G. M., & Verbeek, M. M. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.320 · Cited by 84
Microglial Upregulation of Progranulin as a Marker of Motor Neuron Degeneration
Philips, T., De Muynck, L., Nguyen Thi Thu, H., Weynants, B., Vanacker, P., Dhondt, J., Sleegers, K., Schelhaas, H. J., Verbeek, M., Vandenberghe, R., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181fc9aea · Cited by 83
Raitano, S., Ordovàs, L., De Muynck, L., Guo, W., Espuny-Camacho, I., Geraerts, M., Khurana, S., Vanuytsel, K., Tóth, B. I., Voets, T., et al. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.12.001 · Cited by 82
Progranulin deficiency leads to reduced glucocerebrosidase activity
Zhou, X., Paushter, D. H., Pagan, M. D., Kim, D., Nunez Santos, M., Lieberman, R. L., Overkleeft, H. S., Sun, Y., Smolka, M. B., & Hu, F. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212382 · Cited by 82
Pikkarainen, M., Hartikainen, P., & Alafuzoff, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31816a1da2 · Cited by 82
Borroni, B., Archetti, S., Del Bo, R., Papetti, A., Buratti, E., Bonvicini, C., Agosti, C., Cosseddu, M., Turla, M., Di Lorenzo, D., et al. (2010) · Rejuvenation Research · doi:10.1089/rej.2010.1017 · Cited by 82
Whitwell, J. L., Jack, C. R., Baker, M., Rademakers, R., Adamson, J., Boeve, B. F., Knopman, D. S., Parisi, J. F., Petersen, R. C., Dickson, D. W., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.371 · Cited by 83
Self-citationFenoglio, C., Scarpini, E. A., Serpente, M., & Galimberti, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170702 · Cited by 101
Okura, H., Yamashita, S., Ohama, T., Saga, A., Yamamoto-Kakuta, A., Hamada, Y., Sougawa, N., Ohyama, R., Sawa, Y., & Matsuyama, A. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3921 · Cited by 81
The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments
Mackenzie, I. R., & Rademakers, R. (2007) · Neurogenetics · doi:10.1007/s10048-007-0102-4 · Cited by 98
Self-citationAnterior brain glucose hypometabolism predates dementia in progranulin mutation carriers
Jacova, C., Hsiung, G.-Y. R., Tawankanjanachot, I., Dinelle, K., McCormick, S., Gonzalez, M., Lee, H., Sengdy, P., Bouchard-Kerr, P., Baker, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a8237e · Cited by 81
Self-citationCui, Y., Hettinghouse, A., & Liu, C.-J. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.01.002 · Cited by 80
Ramos, E. M., Dokuru, D. R., Van Berlo, V., Wojta, K., Wang, Q., Huang, A. Y., Deverasetty, S., Qin, Y., van Blitterswijk, M., Jackson, J., et al. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12011 · Cited by 80
Self-citationMotor neuron disease and frontotemporal dementia: sometimes related, sometimes not
Hardy, J., & Rogaeva, E. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.006 · Cited by 94
Atypical parkinsonian syndromes: a general neurologist's perspective
Deutschländer, A., Ross, O. A., Dickson, D. W., & Wszołek, Z. K. (2017) · European Journal of Neurology · doi:10.1111/ene.13412 · Cited by 104
Self-citationValdez, C., Ysselstein, D., Young, T. J., Zheng, J., & Krainc, D. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddz229 · Cited by 80
Alzheimer disease‐like clinical phenotype in a family with FTDP‐17 caused by a MAPT R406W mutation
Lindquist, S. G., Holm, I. E., Schwartz, M., Law, I., Stokholm, J., Batbayli, M., Waldemar, G., & Nielsen, J. E. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02069.x · Cited by 80
Primary Progressive Aphasia: A 25-year Retrospective
Mesulam, M. M. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815bf7e1 · Cited by 111
An algorithm for genetic testing of frontotemporal lobar degeneration
Goldman, J. S., Rademakers, R., Huey, E. D., Boxer, A. L., Mayeux, R., Miller, B. L., & Boeve, B. F. (2011) · Neurology · doi:10.1212/wnl.0b013e31820a0d13 · Cited by 79
Self-citationAnimal models reveal role for tau phosphorylation in human disease
Götz, J., Gladbach, A., Pennanen, L., van Eersel, J., Schild, A., David, D. C., & Ittner, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.008 · Cited by 93
Impairment of Lysosome Function and Autophagy in Rare Neurodegenerative Diseases
Darios, F. D., & Stévanin, G. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.033 · Cited by 91
Lüningschrör, P., Werner, G., Stroobants, S., Kakuta, S., Dombert, B., Sinske, D., Wanner, R., Lüllmann-Rauch, R., Wefers, B., Wurst, W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.060 · Cited by 78
Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer’s Disease
Yang, Y., & Zhang, Z. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00110 · Cited by 77
Tatom, J. B., Wang, D. B., Dayton, R. D., Skalli, O., Hutton, M. L., Dickson, D. W., & Klein, R. L. (2009) · Molecular Therapy · doi:10.1038/mt.2009.3 · Cited by 78
Self-citationBigio, E. H., Mishra, M., Hatanpaa, K. J., White, C. L., Johnson, N., Rademaker, A., Weitner, B. B., Deng, H.-X., Dubner, S. D., Weintraub, S., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0681-2 · Cited by 78
The molecular basis of frontotemporal dementia
Neumann, M., Tolnay, M., & Mackenzie, I. R. A. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001136 · Cited by 78
Self-citationPathological correlates of frontotemporal lobar degeneration in the elderly
Baborie, A., Griffiths, T. D., Jaros, E., McKeith, I. G., Burn, D. J., Richardson, A. M. T., Ferrari, R., Moreno, J. H., Momeni, P., DuPlessis, D., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0765-z · Cited by 89
Self-citation
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.